The World Menopause Congress 2014 Banner

The World Menopause Congress 2014

Categories: , , ,

The 14th World Menopause Congress was held in Cancun Mexico from May 1-4, 2014.

There were numerous sessions covering female sexual health in the peri and postmenopausal woman. One symposium dealt exclusively with an Androgen Update. World leaders in the field Professor Susan Davis (Australia), Dr Jan Shifren (USA) and Dr Karen Miller (USA) outlined the physiology, efficacy and range of therapeutic uses of testosterone in women. There was an overwhelming sense of frustration from speakers (and delegates) over the continued lack of access of women to approved therapeutic options for managing sexual dysfunction.

At another session Dr Wulf Utian (USA) outlined the problems with the compounding pharmacy industry in the USA and the lack of quality control, efficacy and detailed some of the misadventures with the use of compounded hormones. Dr James Simon (USA) gave an inspiring presentation on female sexual dysfunction (FSD) after menopause. He highlighted the complete imbalance in therapeutic options available to men as compared to women in the USA a situation mirrored worldwide. I encourage everyone to sign and support the International Society for the Study of Women’s Sexual Health (ISSWSH) online petition.

 

Latest News


Free CPD Education: Diagnose & Manage HSDD Free CPD Education: Diagnose & Manage HSDD

Empower Your Practice: Address HSDD with Confidence Hypoactive Sexual Desire Disorder (HSDD) is a common yet often overlooked concern in general practice—especially among postmenopausal… Continue Reading →

PBAC says NO! PBAC says NO!

The outcome of the November 2025 meeting of the Pharmaceuticals Benefits Advisory Committee (PBAC) has determined that AndroFeme® 1 testosterone cream for the treatment… Continue Reading →